Tokyo, Sept. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058931) titled 'Study on the functionality of an amino acid mix food for healthy adult women with skin aging problems' on Sept. 2.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Ajinomoto Co.,Inc.

Condition: Condition - N/A (healthy adults) Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to examine the effects of the test food on indices of skin aging in subjects consuming the food for 12 weeks. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Subjects will consume the test food for 12 weeks. Interventions/Control_2 - Subjects will consume placebo food for 12 weeks.

Eligibility: Age-lower limit - 30 years-old

Gender - Female Key inclusion criteria - [1]Female aged between 30 and 65 at the time of informed consent [2]Individuals who are healthy and have no chronic physical disease including skin disease. [3]Individuals who are aware of skin deterioration such as elasticity and sagging [4] Individuals who are aware that they consume a lot of carbohydrates [5]Individuals whose written informed consent has been obtained. [6]Individuals who can come to the designated venue for this study and be inspected. [7]Individuals judged appropriate for this study by a responsible doctor. Key exclusion criteria - Individuals (who) [1]currently suffering from any disease and undergoing drug treatment. [2]with atopic dermatitis, skin disease symptoms, and diseases such as liver, kidney, heart, lung, blood, digestive organs, mental disorders, and severe anemia. Also, those with a history of serious illness. [3]undergoing hormone replacement therapy, and those with menopausal symptoms that have a strong physical and psychological impact. [4] have a history of taking or applying medications for the purpose of treating a medical condition within the past month (excluding occasional use for headaches, menstrual cramps, colds, etc.) [5] may be pregnant, pregnant women, breastfeeding women. [6] may experience allergic symptoms due to ingredients contained in the test food, and individuals who may experience severe allergic symptoms due to other foods or medicines. [7] have fewer than two bowel movements per week (suspected chronic constipation) and individuals who may use laxatives or constipation medications (including laxatives) during the test period. [8] have continuously consumed or used foods containing collagen, L-histidine, or L-threonine, or pharmaceuticals, quasi-drugs, specific health use foods, functional foods, health foods, or supplements claiming skin-improving or anti-glycation effects within the past three months, or individuals who plan to consume or use these products during the trial period. [9]with smoking habits. [10]with irregular eating habits (e.g., eating only one meal per day, skipping dinner, etc.) or picky eating tendencies. [11]consume an average of 60g or more of pure alcohol per day. [12]may need to change their lifestyle during the study period (e.g., night shifts, long-term business trips, etc.). etc. Target Size - 84

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 08 Month 28 Day Date of IRB - 2025 Year 08 Month 28 Day Anticipated trial start date - 2025 Year 09 Month 03 Day Last follow-up date - 2026 Year 05 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067397

Disclaimer: Curated by HT Syndication.